Analysts expect Belite Bio, Inc to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 133.17 M | 22.54 M | 37.47 M | 39.95 M | 212.15 M | 133.48 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 121.46 M | 19.94 M | 35.16 M | 37.14 M | 173.96 M | 123.89 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 127.31 M | 21.24 M | 36.31 M | 38.54 M | 193.06 M | 128.69 M |
Analysts expect Belite Bio, Inc to report earnings per share of -0.75 for Q3 26, against a range of -0.82 to -0.68. The most recent reported quarter, Q2 26, came in at -0.70, a 13.6% beat against the -0.81 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.28 | -0.32 | -0.45 | -0.50 | -0.65 | -0.38 | -0.34 | -0.70 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.28 | -0.27 | -0.33 | -0.38 | -0.48 | -0.52 | -0.61 | -0.75 | -0.68 | -0.81 | 1.65 | -0.80 | -0.43 | -0.24 | 3.01 | 1.19 | ||||||||||
| Low Estimate | -0.34 | -0.31 | -0.39 | -0.42 | -0.56 | -0.64 | -0.73 | -0.87 | -0.82 | -0.95 | 1.39 | -0.88 | -0.47 | -0.28 | 2.71 | 0.97 | ||||||||||
| Consensus Estimate | -0.31 | -0.29 | -0.36 | -0.40 | -0.52 | -0.58 | -0.67 | -0.81 | -0.75 | -0.88 | 1.52 | -0.84 | -0.45 | -0.26 | 2.86 | 1.08 |
Pull Wall Street consensus for Belite Bio, Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BLTE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BLTE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BLTE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();